| 2026-08-21 16:50 |
8-K |
["1.01", "9.01"] |
other |
0.15
|
ATM offering agreement with Jefferies for $75M stock issuance; generic language about potential future acquisitions with no definitive commitments. |
SEC · detail |
| 2026-08-12 16:56 |
8-K |
["1.01"] |
other |
0.05
|
Securities purchase agreement for convertible notes financing; unrelated to M&A activity. |
SEC · detail |
| 2026-08-06 16:13 |
8-K |
["1.01"] |
material agreement |
0.05
|
Debt settlement with Leonite; no M&A signal. Company paying down secured convertible note with cash and stock. |
SEC · detail |
| 2026-07-29 17:00 |
8-K |
["1.02"] |
other |
0.05
|
Termination of at-market equity offering agreement; no M&A signal. |
SEC · detail |
| 2026-07-07 09:18 |
8-K |
["9.01"] |
other |
0.15
|
Amendment filing for private placement with Leonite Fund I; no M&A indicators present. |
SEC · detail |
| 2026-07-02 16:30 |
8-K |
["1.01"] |
other |
0.05
|
Convertible debt financing for clinical development; no M&A signal. |
SEC · detail |
| 2026-04-30 16:06 |
8-K |
["7.01", "9.01"] |
other |
0.05
|
Routine regulatory update on OST-HER2 program and EMA rolling review; no M&A signals. |
SEC · detail |